Novel Molecular Assays Using Droplet Digital PCR Enable Rapid Detection of Clinically Relevant Cancer Mutations

Dr Curtis Hughesman, Postdoctoral Researcher, BC Cancer Research Center and University of British Columbia, explains how droplet digital PCR is enabling him to develop novel molecular diagnostics assays as laboratory developed tests (LDT's) for the detection of cancer. Hear how he has developed a fast method to screen clinically relevant hotspot mutations, and a digital assay to detect a translocations in DNA, such as one associated with AML. In the future, Dr Hugesman hopes to translate the assays into the clinical genetics lab to enable earlier detection of cancer to help give patients better outcomes.